


Ask a doctor about a prescription for LOSARTAN/HYDROCHLOROTHIAZIDE SANDOZ 100mg/25mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Losartan/Hydrochlorothiazide Sandoz 100 mg/25 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Potassium losartan belongs to a group of medicines called angiotensin-II receptor antagonists. These cause the relaxation of blood vessels, which leads to a decrease in blood pressure.
Hydrochlorothiazide belongs to a group of medicines called diuretics. Hydrochlorothiazide makes the kidneys eliminate more salts. This also helps reduce blood pressure.
Losartan/Hydrochlorothiazide 100 mg/25 mg is used to treat high blood pressure in patients who do not respond sufficiently to treatment with losartan/hydrochlorothiazide 50 mg/12.5 mg.
Do not take Losartan/Hydrochlorothiazide Sandoz:
If you think any of the above conditions apply to you, consult your doctor or pharmacist.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Losartan/Hydrochlorothiazide Sandoz.
You must inform your doctor if you think you are pregnant (or might become pregnant). Losartan/hydrochlorothiazide is not recommended at the beginning of pregnancy and should not be used if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at this stage (see section Pregnancy).
It is important that you inform your doctor before taking Losartan/Hydrochlorothiazide Sandoz:
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking losartan/hydrochlorothiazide. Your doctor will decide whether to continue treatment. Do not stop taking losartan/hydrochlorothiazide on your own.
Your doctor may monitor your kidney function, blood pressure, and blood electrolyte levels (e.g. potassium) at regular intervals.
See also the information under the heading “Do not take Losartan/Hydrochlorothiazide Sandoz”.
Children and adolescents
The safety and efficacy of losartan/hydrochlorothiazide in children and adolescents under 18 years of age have not been established. Losartan/hydrochlorothiazide should not be given to children and adolescents.
Ask your doctor if you are subject to doping control, as losartan/hydrochlorothiazide contains an active substance that may test positive in a doping control.
Other medicines and Losartan/Hydrochlorothiazide Sandoz
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor may need to change your dose and/or take other precautions if you are taking:
Please inform your doctor if you are taking losartan/hydrochlorothiazide and are going to undergo a radiographic procedure and need to take iodinated contrast media.
Losartan/Hydrochlorothiazide Sandoz with food and drinks
Excessive salt in the diet may counteract the effect of losartan/hydrochlorothiazide.
Losartan/hydrochlorothiazide can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You must inform your doctor if you think you are pregnant (or might become pregnant). Normally, your doctor will advise you to stop taking losartan/hydrochlorothiazide before you become pregnant or as soon as you know you are pregnant and will advise you to take a different medicine instead of losartan/hydrochlorothiazide. Losartan/hydrochlorothiazide is not recommended at the beginning of pregnancy and should not be used if you are more than 3 months pregnant, as it may cause serious harm to your baby if used from the third month of pregnancy.
Breastfeeding
Consult your doctor if you are breastfeeding or plan to start breastfeeding. Losartan/hydrochlorothiazide is not recommended for breastfeeding mothers and your doctor may choose a different treatment if you want to breastfeed.
If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
When starting treatment with this medicine, you should not perform tasks that require special attention (e.g. driving a car or using hazardous machinery) until you know how your medicine affects you.
Losartan/Hydrochlorothiazide Sandoz contains lactose.
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide the appropriate dose of losartan/hydrochlorothiazide depending on your condition and whether you are taking other medicines. It is important to keep taking losartan/hydrochlorothiazide as long as your doctor prescribes it to maintain constant control of your blood pressure.
Take the tablet with a glass of water. It can be taken with or without food.
Use in adults
The usual dose of losartan/hydrochlorothiazide 100 mg/25 mg is one tablet once a day.
Use in elderly patients
Generally, no dose adjustment is necessary in elderly patients.
Use in hemodialysis and renal failure
In case of moderate kidney problems, it is generally not necessary to adjust the dose. Do not take losartan/hydrochlorothiazide if you have severe kidney failure. Losartan/hydrochlorothiazide is not recommended in patients on hemodialysis.
Use in liver failure
Losartan/hydrochlorothiazide should be used with caution in patients with mild to moderate liver failure.
Do not take losartan/hydrochlorothiazide if your liver function is severely impaired (see section 2 “Do not take Losartan/Hydrochlorothiazide Sandoz”).
Use in children and adolescents
Losartan/hydrochlorothiazide should not be administered to children and adolescents under 18 years of age.
Use in black patients
A dose adjustment may be necessary as efficacy may be reduced in black patients compared to non-black patients.
If you take more Losartan/Hydrochlorothiazide Sandoz than you should
In case of overdose, contact your doctor immediately for immediate medical attention. Overdose may cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition, and dehydration. If you have taken more Losartan/Hydrochlorothiazide Sandoz than you should, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used.
If you forget to take Losartan/Hydrochlorothiazide Sandoz
Do not take a double dose to make up for forgotten doses. Take your next dose as usual.
If you stop taking Losartan/Hydrochlorothiazide Sandoz
Always consult your doctor if you want to stop taking this medicine. Although you may feel well, you may need to continue taking this medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you experience the following, stop taking losartan/hydrochlorothiazide tablets and inform your doctor immediately or go to the emergency department of your nearest hospital:
A severe allergic reaction(skin rash, itching, swelling of the face, lips, mouth, or throat that can cause difficulty swallowing or breathing).
This is a serious but rare adverse effect, affecting more than 1 in 10,000 patients, but less than 1 in 1,000 patients. It may require urgent medical attention or hospitalization.
Acute respiratory distress (symptoms include severe respiratory distress, fever, weakness, and confusion), this is a very rare adverse reaction (may affect up to 1 in 10,000 people).
The following adverse effects have been reported:
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Frequency Not Known(frequency cannot be estimated from the available data):
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use Losartan/Hydrochlorothiazide Sandoz after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Alu/Alu Blister: store below 30 °C.
Aclar/Alu Blister: store below 30 °C
Bottle: keep the bottle tightly closed to protect it from moisture.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Losartan/Hydrochlorothiazide Sandoz
Core:lactose monohydrate, microcrystalline cellulose, pregelatinized corn starch, magnesium stearate, anhydrous colloidal silica.
Coating:hypromellose, hydroxypropylcellulose, yellow iron oxide (E172), titanium dioxide (E171), macrogol (400), talc.
Appearance of the Product and Package Contents
Losartan/Hydrochlorothiazide Sandoz 100 mg/25 mg is presented as film-coated tablets, which are light yellow in color, round, biconvex, and have a diameter of 10 mm.
They are packaged in blisters with an aluminum foil or in plastic bottles with or without a child-resistant screw cap.
Blister: 7, 10, 14, 28, 30, 50, 56, 60, 84, 90, 98, and 100 film-coated tablets.
Blister (unit dose): 50 film-coated tablets.
Bottle: 100 and 250 film-coated tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Lek Pharmaceuticals d.d.
Verovskova 57
SI-1526 Ljubljana
Slovenia
or
Lek S.A.,
Ul. Domaniewska 50 C
02-672 Warsaw
Poland
or
Salutas Pharma GmbH
Otto von Guericke Allee 1
39179 Barleben, Germany
or
Salutas Pharma GmbH
Dieselstrasse 5
70839 Gerlingen
Germany
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Germany: Losartan-HCT Sandoz 100 mg/25 mg Filmtabletten
Austria: Losartan-HCT Sandoz 100 mg/25 mg Filmtabletten
Belgium: Co-Losartan Sandoz 100 mg/25 mg filmomhulde tabletten
Denmark: Ancozan Comp
France: LOSARTÁN/ HYDROCHLOROTHIAZIDE Sandoz 100 mg/25 mg, comprimé pelliculé
Netherlands: KaliumLosartán/Hydrochloorthiazide Sandoz 100/25 mg, filmomhulde tabletten
Italy: LOSARTÁN IDROCLOROTIAZIDE SANDOZ 100 mg + 25 mg compresse rivestite con film
Portugal: Losartán + Hidroclorotiazida Sintano
United Kingdom (Northern Ireland): Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Film-coated Tablets
Czech Republic: Sangona COMBI 100 mg/25 mg
Sweden: Losartan/Hydrochlorothiazide Sandoz 100 mg/25 mg filmdragerade tabletter
Date of the Last Revision of this Leaflet: February 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of LOSARTAN/HYDROCHLOROTHIAZIDE SANDOZ 100mg/25mg FILM-COATED TABLETS in November, 2025 is around 5.84 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LOSARTAN/HYDROCHLOROTHIAZIDE SANDOZ 100mg/25mg FILM-COATED TABLETS – subject to medical assessment and local rules.